Medikly, Inc., a New York-based software-as-a-service (SaaS) technology provider for pharmaceutical brands and agencies, closed a $1.2m Series A funding.
The round was led by Easton Capital Investment Group.
The company, which recently graduated from Blueprint Health, a New York City-based startup accelerator, intends to use the capital to enhance the development of its marketing platform.
Launched in 2011 by CEO Venkat Gullapalli, MD, Medikly provides pharmaceutical marketers with an enterprise-grade, multi-channel marketing solution that combines social, content, and big-data analytics to deliver insights to better understand physician behaviors and preferences and optimize campaign spend.
In conjunction with the funding, Kresimir Letinic of Easton Capital has joined the company’s board of directors. James Golden, Ph.D., Managing Director, Life Science Analytics at Accenture, has become a board observer.
Medikly is hiring (read here).